EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Improving Radiation Therapy in Pancreatic Cancer Through Radiosensitization Strategies

Julie Dardare, Nicolas Martz, Andréa Witz, Margaux Betz, Cassandra Michel, Pauline Gilson, Jean-Louis Merlin, Aurélien Lambert, Alexandre Harle

International Journal of Radiation Oncology*Biology*Physics · 2026-02 · 124 (2) · 395-414

DOI: 10.1016/j.ijrobp.2025.09.013 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2026-02. Verfasst von Julie Dardare und 8 weiteren Autor:innen. Beteiligte Einrichtung: Service de Médecine de Précision et Recherche Translationnelle, Institut de Cancérologie de Lorraine, Vandœuvre-lès-Nancy, France. Electronic address…. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Radiation-Sensitizing Agents, Radiation Tolerance. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 179 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Radiation therapy (RT) is a mainstay of treatment for a myriad of cancers; however, it remains a controversial option in the management of patients with pancreatic cancer. The prognosis for this disease remains one of the poorest, despite recent advances in chemotherapy, which still has limited efficacy and suffers from multiple forms of resistance. The application of RT in patients with pancreatic cancer remains largely institution and provider dependent. Despite advances in RT where higher doses can be delivered while sparing adjacent normal organs, local control remains a problem, highlighting the necessity for improvements in the current RT approach. Emerging strategies are currently being developed with the aim of improving the effects of RT using "radiosensitization" mechanisms. The objective of radiosensitization is to either enhance DNA damage induced by RT or to prevent its repair or to impair the RT-resistance-associated components of the tumor. The process of radiosensitization can be achieved through the use of conventional chemotherapy agents or by novel molecules that inhibit DNA damage response effectors, as well as cell cycle checkpoints. Additionally, nanoparticles with a high atomic number have the potential to act as radiosensitizers by enhancing the effects of RT specifically in tumor cells. Another avenue of radiosensitization entails the combination of immunotherapy with immune checkpoint inhibitors to increase the immunomodulatory impact of RT. The radiosensitivity of pancreatic ductal adenocarcinoma may also be enhanced by targeting components of the tumor microenvironment or metabolic characteristics associated with resistance to RT. This review aims to provide a comprehensive overview of cutting-edge radiosensitization strategies, from their initial preclinical studies to their current status in clinical trials.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsRadiation-Sensitizing AgentsRadiation ToleranceHumansDNA DamageNanoparticlesDNA RepairCell Cycle Checkpoints

Substanzen

Radiation-Sensitizing Agents

Autor:innen und Institutionen

  • Service de Médecine de Précision et Recherche Translationnelle, Institut de Cancérologie de Lorraine, Vandœuvre-lès-Nancy, France. Electronic address: j.dardare@nancy.unicancer.fr.
  • Academic Department of Radiation Therapy & Brachytherapy, Institut de Cancérologie de Lorraine, Vandœuvre-lès-Nancy, France.
  • Service de Médecine de Précision et Recherche Translationnelle, Institut de Cancérologie de Lorraine, Vandœuvre-lès-Nancy, France; Université de Lorraine, Centre National de la Recherche Scientifique (CNRS), Unité Mixte…
  • Service de Médecine de Précision et Recherche Translationnelle, Institut de Cancérologie de Lorraine, Vandœuvre-lès-Nancy, France.

Zitieren

APA

Dardare, J., Martz, N., Witz, A., Betz, M., Michel, C., Gilson, P., Merlin, J. L., Lambert, A., & Harle, A. (2026). Improving Radiation Therapy in Pancreatic Cancer Through Radiosensitization Strategies. International Journal of Radiation Oncology*Biology*Physics, 124(2), 395-414. https://doi.org/10.1016/j.ijrobp.2025.09.013

Vancouver

Dardare J, Martz N, Witz A, Betz M, Michel C, Gilson P, et al. Improving Radiation Therapy in Pancreatic Cancer Through Radiosensitization Strategies. International Journal of Radiation Oncology*Biology*Physics. 2026;124(2):395-414. doi:10.1016/j.ijrobp.2025.09.013

BibTeX
@article{Dardare2026,
  author = {Dardare, Julie and Martz, Nicolas and Witz, Andréa and Betz, Margaux and Michel, Cassandra and Gilson, Pauline and Merlin, Jean-Louis and Lambert, Aurélien and Harle, Alexandre},
  title = {Improving Radiation Therapy in Pancreatic Cancer Through Radiosensitization Strategies},
  journal = {International Journal of Radiation Oncology*Biology*Physics},
  year = {2026},
  volume = {124},
  number = {2},
  pages = {395--414},
  doi = {10.1016/j.ijrobp.2025.09.013}
}
Kostenlos starten →